Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medical Specialties (26)
- Public Health (10)
- Medical Sciences (8)
- Primary Care (7)
- Surgery (7)
-
- Health Services Research (6)
- Life Sciences (6)
- Cardiology (5)
- Trauma (5)
- Other Medical Specialties (4)
- Diseases (3)
- Psychiatry (3)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (2)
- Arts and Humanities (2)
- Cardiovascular Diseases (2)
- Chemicals and Drugs (2)
- Community Health and Preventive Medicine (2)
- Critical Care (2)
- Health Services Administration (2)
- Latin American Languages and Societies (2)
- Mental and Social Health (2)
- Neurology (2)
- Oncology (2)
- Therapeutics (2)
- Alternative and Complementary Medicine (1)
- Cancer Biology (1)
- Cell and Developmental Biology (1)
- Chemical Actions and Uses (1)
- Clinical Epidemiology (1)
- Publication
- File Type
Articles 31 - 31 of 31
Full-Text Articles in Medicine and Health Sciences
Cross-Subtype Antibody And Cellular Immune Responses Induced By A Polyvalent Dna Prime-Protein Boost Hiv-1 Vaccine In Healthy Human Volunteers, Shixia Wang, Jeffrey Kennedy, Kim West, David Montefiori, Scott Coley, John Lawrence, Siyuan Shen, Sharone Green, Alan Rothman, Francis Ennis, James Arthos, Ranajit Pal, Phillip Markham, Shan Lu
Cross-Subtype Antibody And Cellular Immune Responses Induced By A Polyvalent Dna Prime-Protein Boost Hiv-1 Vaccine In Healthy Human Volunteers, Shixia Wang, Jeffrey Kennedy, Kim West, David Montefiori, Scott Coley, John Lawrence, Siyuan Shen, Sharone Green, Alan Rothman, Francis Ennis, James Arthos, Ranajit Pal, Phillip Markham, Shan Lu
Sharone Green
An optimally effective AIDS vaccine would likely require the induction of both neutralizing antibody and cell-mediated immune responses, which has proven difficult to obtain in previous clinical trials. Here we report on the induction of Human Immunodeficiency Virus Type-1 (HIV-1)-specific immune responses in healthy adult volunteers that received the multi-gene, polyvalent, DNA prime-protein boost HIV-1 vaccine formulation, DP6-001, in a Phase I clinical trial conducted in healthy adult volunteers of both genders. Robust cross-subtype HIV-1-specific T cell responses were detected in IFNgamma ELISPOT assays. Furthermore, we detected high titer serum antibody responses that recognized a wide range of primary HIV-1 …